IVZ vs PBYI · rev $3.57B vs P/E 4.3, rev $56.5M
Invesco Plc (IVZ) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
IVZ currently screens at market cap $12.76B. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the IVZ and PBYI stock pages for the full models.
Not investment advice.